Search Results - "Pomeranz, K. M."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Unravelling the links between malignancy, cytokines and neutrophilic eruptions by Seminara, N.M., Pomeranz, M.K.

    Published in British journal of dermatology (1951) (01-10-2017)
    “…Linked Article: Iwata et al. Br J Dermatol 2017; 177:1122–1126…”
    Get full text
    Journal Article
  2. 2

    Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells by Goto, T., Takano, M., Albergaria, André, Briese, J., Pomeranz, K. M., Cloke, B., Fusi, L., Feroze-Zaidi, F., Maywald, N., Sajin, M.

    Published in Oncogene (03-01-2008)
    “…The forkhead transcription factor FOXO1, a downstream target of phosphatidylinositol-3-kinase/Akt signalling pathway, regulates cyclic differentiation and…”
    Get full text
    Journal Article
  3. 3

    Lichenoid vulvar disease: A review by Fruchter, R., Melnick, L., Pomeranz, M.K.

    “…Vulvar dermatoses are common, potentially debilitating conditions that can be seen by a variety of medical specialists. Lichenoid vulvar diseases, namely…”
    Get full text
    Journal Article
  4. 4

    Acne: a side‐effect of masculinizing hormonal therapy in transgender patients by Motosko, C.C., Zakhem, G.A., Pomeranz, M.K., Hazen, A.

    Published in British journal of dermatology (1951) (01-01-2019)
    “…Summary Background Masculinizing hormonal treatment in transgender men has the potential to increase the level of androgens at end organs, including the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses by Tseng, Stephanie, Pak, Grace, Washenik, Kenneth, Keltz Pomeranz, Miriam, Shupack, Jerome L

    “…Thalidomide, a hypnosedative drug introduced in the 1950s, has been used in a variety of dermatologic conditions during the past few decades. Although…”
    Get full text
    Book Review Journal Article
  7. 7

    Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses by Kitchin, Jennifer E. Silverman, Pomeranz, Miriam Keltz, Pak, Grace, Washenik, Ken, Shupack, Jerome L.

    “…Oral mycophenolic acid (MPA) therapy has been investigated in the treatment of moderate to severe psoriasis since the early 1970s and has been found to be both…”
    Get full text
    Journal Article
  8. 8

    Papular acantholytic dyskeratosis of the vulva associated with familial Hailey-Hailey disease by Yu, W. Y., Ng, E., Hale, C., Hu, S., Pomeranz, M. K.

    Published in Clinical and experimental dermatology (01-08-2016)
    “…Summary Papular acantholytic dyskeratosis (PAD) of the vulva is a rare, chronic disorder first described in 1984. It presents in young women as white to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A side‐effect of masculinizing hormonal therapy by Motosko, C.C., Zakhem, G.A., Pomeranz, M.K., Hazen, A.

    Published in British journal of dermatology (1951) (01-01-2019)
    “…Summary Acne is a known side effect of masculinizing hormonal therapy used in transgender men. In all people with acne, it can contribute to depression, body…”
    Get full text
    Journal Article
  11. 11

    Nonbacterial Causes of Lymphangitis with Streaking by Cohen, Brandon E, Nagler, Arielle R, Pomeranz, Miriam Keltz

    “…Lymphangitic streaking, characterized by linear erythema on the skin, is most commonly observed in the setting of bacterial infection. However, a number of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses by Silverman Kitchin, Jennifer E., Pomeranz, Miriam Keltz, Pak, Grace, Washenik, Ken, Shupack, Jerome L.

    “…Oral mycophenolic acid (MPA) therapy has been investigated in the treatment of moderate to severe psoriasis since the early 1970s and has been found to be both…”
    Get full text
    Journal Article
  14. 14

    Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt by Sunters, Andrew, Madureira, Patricia A, Pomeranz, Karen M, Aubert, Muriel, Brosens, Jan J, Cook, Simon J, Burgering, Boudewijn M T, Coombes, R Charles, Lam, Eric W-F

    Published in Cancer research (Chicago, Ill.) (01-01-2006)
    “…The microtubule-targeting compound paclitaxel is often used in the treatment of endocrine-resistant or metastatic breast cancer. We have previously shown that…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Art of prevention: The importance of dermatologic care when using aromatase inhibitors by Behbahani, Sara, Geisler, Amaris, Kolla, Avani, Dreker, Margaret Rush, Kaunitz, Genevieve, Pomeranz, Miriam K.

    “…As of January 2021, there are more than 3.8 million women in the United States with a history of breast cancer. The current standard of care for breast cancer…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Chronic cutaneous lupus erythematosus in vitiligo by Johnson, Hillary, Bossenbroek, Nicole M, Rosenman, Karla, Meehan, Shane A, Robles, Mirin, Pomeranz, Miriam K

    Published in Dermatology online journal (01-10-2008)
    “…A 49-year-old woman presented with a seven-year history of pruritic, erythematous, scaling plaques on sun-exposed skin that localized only to pre-existing…”
    Get full text
    Journal Article